GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Operating Income 2010–2020
GT Biopharma, Inc. annual/quarterly operating income history and growth rate from 2010 to 2021. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- GT Biopharma, Inc. operating income for the quarter ending September 30, 2021 was -6.0 M, a 206.12% increase year-over-year.
- GT Biopharma, Inc. operating income for the twelve months ending September 30, 2021 was -41.3 M, a 325.54% increase year-over-year.
- GT Biopharma, Inc. annual operating income for 2020 was -6.8 M, a 142.13% decrease from 2019.
- GT Biopharma, Inc. annual operating income for 2019 was 16.1 M, a 111.84% decrease from 2017.
- GT Biopharma, Inc. annual operating income for 2017 was -135.6 M, a 1346.23% increase from 2016.
- GT Biopharma, Inc. annual operating income for 2016 was -9.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GT Biopharma, Inc. Operating Income — FAQ
GT Biopharma, Inc. (GTBP) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is GT Biopharma, Inc.'s operating income?
GT Biopharma, Inc. (GTBP) reported operating income of -$7M for fiscal 2020.
Where can I see GTBP's operating income history?
The chart and table above show GT Biopharma, Inc.'s operating income by year and by quarter, including the growth rate.